Lindbrook Capital’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$1.16K Buy
26
+14
+117% +$753 ﹤0.01% 2423
2024
Q4
$659 Sell
12
-15
-56% -$759 ﹤0.01% 2561
2024
Q3
$1.14K Sell
27
-11
-29% -$523 ﹤0.01% 2473
2024
Q2
$1.74K Buy
38
+11
+41% +$519 ﹤0.01% 2382
2024
Q1
$1.41K Buy
27
+1
+4% +$44 ﹤0.01% 2348
2023
Q4
$926 Buy
26
+11
+73% +$383 ﹤0.01% 2481
2023
Q3
$503 Sell
15
-16
-52% -$555 ﹤0.01% 2541
2023
Q2
$1.17K Buy
31
+20
+182% +$657 ﹤0.01% 2336
2023
Q1
$323 Hold
11
﹤0.01% 2670
2022
Q4
$290 Sell
11
-9
-45% -$214 ﹤0.01% 2683
2022
Q3
$0 Buy
+20
New +$546 ﹤0.01% 2924

Other funds holding VCEL

Lindbrook Capital's VCEL Position: Q1 2025 in Review

Lindbrook Capital increased its Vericel Corp (VCEL) stake by 117% in Q1 2025, buying an estimated $753 and bringing the position to 26 shares worth $1.16K. The position accounts for ﹤0.01% of the portfolio, ranked #2423.

Lindbrook Capital first reported a position in VCEL in Q3 2022 and has held it in 11 quarters since. The position peaked at $1.74K in Q2 2024. 277 funds tracked by Wall St. Rank hold VCEL as of Q1 2025.

  • Lindbrook Capital held 26 shares of Vericel Corp worth $1.16K as of Q1 2025.
  • Lindbrook Capital bought 14 Vericel Corp shares in Q1 2025, an estimated $753.
  • Vericel Corp made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2423 holding.
  • Lindbrook Capital first reported a position in Vericel Corp in Q3 2022 and has held it in 11 quarters since.
  • Lindbrook Capital's Vericel Corp position peaked at $1.74K in Q2 2024.
  • 277 funds tracked by Wall St. Rank held Vericel Corp as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.